New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors. 2009

Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
Laboratoire de Chimie des Materiaux Organiques and Laboratoire de Chimie Moleculaire Structurale, Facultes Universitaires Notre-Dame de la Paix, B-5000 Namur, Belgium.

Several 5-ethyl-6-methyl-4-cycloalkyloxy-pyridin-2(1H)-ones were synthesized and evaluated for their anti HIV-1 activities against wild-type virus and clinically relevant mutant strains. A racemic mixture (10) with methyl substituents at positions 3 and 5 of the cyclohexyloxy moiety had potent antiviral activity against wild-type HIV-1. Subsequent stereoselective synthesis of a stereoisomer displaying both methyl groups in equatorial position was found to have the best EC(50). Further modulations focused on position 3 of the pyridinone ring improved the antiviral activity against mutant viral strains. Compounds bearing a 3-ethyl (22) or 3-isopropyl group (23) had the highest activity against wild-type HIV-1 and displayed low-nanomolar potency against several clinically relevant mutant strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
September 1991, Journal of medicinal chemistry,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
April 2023, Communications chemistry,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
November 2006, PLoS pathogens,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
October 2001, Expert opinion on emerging drugs,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
January 1996, Biochemistry,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
November 1995, Journal of medicinal chemistry,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
February 1999, GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
September 2009, Journal of molecular graphics & modelling,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
March 2013, Bioorganic & medicinal chemistry,
Kiet Le Van, and Christine Cauvin, and Stéphane de Walque, and Benoît Georges, and Sandro Boland, and Valérie Martinelli, and Dominique Demonté, and François Durant, and László Hevesi, and Carine Van Lint
February 1992, AIDS research and human retroviruses,
Copied contents to your clipboard!